menu
    • menu

    Company profile for Zhejiang Hisoar Pharmaceutical

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    Contact Supplier

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zhejiang Hisoar Pharmaceutical Co., Ltd. is located in Taizhou, Zhejiang. It is an IPO-listed company held by the DanKong Group, which mainly manufactures APIs, Formulations, Fine Chemicals, Dyestuffs, and Dyestuff Intermediates. It is one of the top 100 innovative companies in the national pharmaceutical industry. The main product categories are antibiotics, cardiovascular, hypoglycemic, and others, fine chemicals, formulatio...
    Zhejiang Hisoar Pharmaceutical Co., Ltd. is located in Taizhou, Zhejiang. It is an IPO-listed company held by the DanKong Group, which mainly manufactures APIs, Formulations, Fine Chemicals, Dyestuffs, and Dyestuff Intermediates. It is one of the top 100 innovative companies in the national pharmaceutical industry. The main product categories are antibiotics, cardiovascular, hypoglycemic, and others, fine chemicals, formulations, dyes, and intermediates. More than 70% of pharmaceutical products are exported, in which Clindamycin series production is in the leading position worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zhejiang Hisoar PharmaceuticalChina Flag
    Country
    Country
    China
    Address
    Address
    No. 100, Waisha Branch Road, Jiaojiang District, Taizhou City, Zhejiang Provin...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hisoar.com/about-en.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/zhejiang-hisoar-pharmaceutical-co-ltd-/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI China

    Not Confirmed

    envelop Contact Supplier

    CPhI China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 569

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaConnecting People, Mentalities & MarketsConnecting People, Mentalities & Markets

    Connecting People, Mentalities & Markets
    Connecting People, Mentalities & Markets

    reelConnecting People, Mentalities & Markets

    This PharmaReel highlights Transo-Pharm USA’s offerings of premium Phyto Cannabidiol (CBD) and Phyto Cannabigerol (CBG) isolates from its cGMP-certified facility inspected by the FDA and ANVISA. The company has an expanded reach across the US and EU.

    Impressions: 656

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    US drug shortages reduce 16% YoY in Q1 2025; CNS drugs, antimicrobials face highest scarcities

    US drug shortages reduce 16% YoY in Q1 2025; CNS drugs, antimicrobials face highest scarcities

    The pharmaceutical industry in the United States continued to grapple with drug shortages during the first quarter (Q1) of 2025. According to the American Society of Health‑System Pharmacists (ASHP), the total number of active shortages stood at 270 as of March 31, 2025 — only slightly below the 277 reported in September 2024, but down 16.4 percent from an all‑time high of 323 reported in Q1 2024.These numbers imply that while dramatic surges in drug shortages may have subsided, underlying vulnerabilities in manufacturing, supply chains, and raw‑material sourcing continue to frustrate efforts towards a durable resolution.A deeper analysis of these drug scarcities reveals that 41 percent of the 270 active shortages first emerged in 2022 or earlier. This implies that many of the current disruptions have become chronic in nature and are exerting pressure on pharmacy operations. View Our Interactive Dashboard on Drug Shortages So Far in 2025 (Free Excel Available)CNS drugs dominate with 49 meds in short supply; antimicrobials face shortage of 39 drugsClass‑specific analysis reveals that central nervous system (CNS) agents remained the most disrupted category, with 49 distinct CNS drugs having faced scarcities during Q1. This group spans anxiolytics (anti-anxiety drugs) such as clonazepam and flurazepam, sedatives like lorazepam and midazolam, and stimulants such as methylphenidate and lisdexamfetamine. These shortages pose two challenges — controlling seizures and managing sedation in acute care settings. After CNS agents, antimicrobials was the second‑largest category, with shortages affecting 39 drugs. Key antibacterial and anti-fungal agents such as cefotaxime sodium powder for injection, clindamycin phosphate, rifampin, and metronidazole find themselves on ASHP’s active‑shortage roster, threatening both routine hospital protocols and emergency sepsis management.Fluids and electrolytes occupied the third spot, with 29 items facing shortage in Q1 2025. Hormone agents, including insulin analogs, ranked fourth with 24 drugs in short supply.Chemotherapy medications rounded out the top five categories, with 23 antineoplastic agents (a broad class of medications used to treat cancer) flagged as actively constrained in Q1 2025. Notable shortages included azacitidine, carboplatin, methotrexate, and streptozocin. View Our Interactive Dashboard on Drug Shortages So Far in 2025 (Free Excel Available) US faces 26 new shortages; Pharmacopeia list warns of 100 vulnerable medicationsThe first quarter saw the emergence of 26 new shortage declarations, emphasizing that even drugs previously deemed reliably sourced can fall into scarcity. The US has been facing a shortage of attention deficit hyperactivity disorder (ADHD) drugs since 2022. The new shortages included ADHD transdermal patch methylphenidate, peginterferon alfa‑2a (Pegasys) used in chronic hepatitis B and C, and bacitracin ophthalmic ointment.The fragility of the pharmaceutical supply chains has been particularly evident in the aftermath of natural disasters. Hurricane Helene’s flooding at Baxter’s Marion, North Carolina, facility deeply affected IV‑solution supply lines. Baxter supplies roughly 60 percent of the US’ IV fluids and the ASHP report listed “hurricane” as the reason behind nine percent of drug shortages, as of January 2025.Regulatory and policy interventions continue to evolve. The US Pharmacopeia’s inaugural Vulnerable Medicines List, launched in 2025, identifies 100 drugs at the highest risk of future shortages, with a particular focus on injectables (comprising 71 percent of the list) and essential hospital care.Antibiotics, medications for pain management and oncology are the other drugs on the list. Although 61 percent of these vulnerable medicines were not in active shortage at the time of listing, their inclusion is intended to galvanize manufacturers and purchasing organizations to bolster inventories.Meanwhile, the Government Accountability Office in the US has called on the Department of Health and Human Services (HHS) to establish a formal coordination mechanism, warning that elimination of the HHS supply‑chain coordinator role in May 2025 risks fragmenting federal response efforts. View Our Interactive Dashboard on Drug Shortages So Far in 2025 (Free Excel Available) Global shortages mirror US patterns; Europe launches monitoring platform Globally, we notice comparable trends. For instance, Europe has rolled out the European Shortages Monitoring Platform (ESMP) this year in order to centralize shortage reporting across member states. Critical‑medicine shortages in the EU — in areas such as oncology, ADHD, and critical care analgesics — mirror US patterns. The European Medicines Agency’s shortage list currently holds 37 human drugs.According to Health Canada’s May 12, 2025 update, its Tier 3 list had 18 drug shortages that are considered to have the greatest impact on Canada’s drug supply and health‑care system. Tier 3 designation is based on medical necessity and minimal availability of alternatives.In hematology and oncology, scarcity of essential drugs like Oncaspar for acute lymphoblastic leukemia, idarubicin and lomustine for leukemias and brain tumors, anagrelide for thrombocythemia, and preservative‑free methotrexate for various malignancies underscore the impact these drug shortages can have on treatment. View Our Interactive Dashboard on Drug Shortages So Far in 2025 (Free Excel Available) Our viewThe global pharma supply chain is dealing with a fresh wave of uncertainties, especially with the likelihood of tariffs on drugs imported into the US. Analysts warn that the proposed pharmaceutical tariffs could exacerbate supply issues.Over 50 percent of drugs used in the US are manufactured abroad. Generic sterile injectable drugs — like chemotherapy medications and IV saline — are particularly vulnerable due to their complex manufacturing processes and low profit margins. Generic drugs (which account for 90 percent of prescriptions filled in the US) could face increased pressure, as many rely on raw materials from China and India. This could result in more severe drug shortages in the future. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 433

    https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities

    #PharmaFlow by PHARMACOMPASS
    22 May 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Chen Zhicheng, member of the party group and deputy director of the Zhejiang
    Chen Zhicheng, member of the party group and deputy director of the Zhejiang

    05 May 2023

    // PRESS RELEASE

    https://www.hisoar.com/news-detail-en.html?id=302

    PRESS RELEASE
    05 May 2023
    Share Share
    A new batch of
    A new batch of "little giant" enterprises in Jiaojiang District was released

    30 Mar 2023

    // PRESS RELEASE

    https://www.hisoar.com/news-detail-en.html?id=295

    PRESS RELEASE
    30 Mar 2023
    Share Share
    Yan Qijun, deputy mayor of Linhai City, and his party visited Haixiang
    Yan Qijun, deputy mayor of Linhai City, and his party visited Haixiang

    23 Mar 2023

    // PRESS RELEASE

    https://www.hisoar.com/news-detail-en.html?id=293

    PRESS RELEASE
    23 Mar 2023
    Share Share
    Zhejiang Science and Technology Award Publicity Information Form
    Zhejiang Science and Technology Award Publicity Information Form

    20 Feb 2022

    // PRESS RELEASE

    https://www.hisoar.com/news-detail-en.html?id=234

    PRESS RELEASE
    20 Feb 2022
    Share Share
    Zhou Hui, President of China Chamber of Commerce for Import and Export
    Zhou Hui, President of China Chamber of Commerce for Import and Export

    24 Jun 2021

    // PRESS RELEASE

    https://www.hisoar.com/news-detail-en.html?id=194

    PRESS RELEASE
    24 Jun 2021
    Share Share
    Zhejiang Hisoar Pharmaceutical issues 500 mln yuan financing bills
    Zhejiang Hisoar Pharmaceutical issues 500 mln yuan financing bills

    22 Nov 2016

    // REUTERS

    http://www.reuters.com/article/idUSL4N1DO1B8

    REUTERS
    22 Nov 2016
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Clindamycin Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    India Med Expo
    Not Confirmed
    arrow

    Clindamycin Hydrochloride

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    India Med Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-01-06

    Pay. Date : 2013-07-09

    DMF Number : 27266

    Submission : 2013-07-08

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2013-190 - Rev 02

    Issue Date : 2024-09-25

    Type : Chemical

    Substance Number : 582

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 303MF10077

    Registrant's Address : No. 23,5th Donghai Avenue Zhejiang Chemical materials base Linhai zone, Linhai City, Zhejiang Province, China.

    Initial Date of Registration : 2021-05-13

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 67321-301

    Start Marketing Date : 2015-02-22

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Ace Biopharm Co., Ltd.

    Registration Date : 2021-04-16

    Registration Number : 20210416-210-J-619

    Manufacturer Name : Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.@HEC PHARM CO., LTD

    Manufacturer Address : No. 23 Donghai 5th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Linhai City, Zhejiang Province China@No.3 Industrial Park of HEC, Yidu, Hubei Province, PR China

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Clindamycin Phosphate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    India Med Expo
    Not Confirmed
    arrow

    Clindamycin Phosphate

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    India Med Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-11-25

    Pay. Date : 2013-07-16

    DMF Number : 27271

    Submission : 2013-07-15

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2013-178 - Rev 02

    Issue Date : 2024-10-14

    Type : Chemical

    Substance Number : 996

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 303MF10045

    Registrant's Address : No. 23,5th Donghai Avenue Zhejiang Chemical materials base Linhai zone, Linhai City, Zhejiang Province, China.

    Initial Date of Registration : 2021-03-15

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 67321-302

    Start Marketing Date : 2015-02-22

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Ace Biopharm Co., Ltd.

    Registration Date : 2021-02-09

    Registration Number : 20210209-210-J-618

    Manufacturer Name : Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Manufacturer Address : No. 23 Donghai 5th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Linhai City, Zhejiang Province China

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Amorolfine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    India Med Expo
    Not Confirmed
    arrow

    Amorolfine Hydrochloride

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    India Med Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2017-091 - Rev 00

    Issue Date : 2023-02-02

    Type : Chemical

    Substance Number : 2756

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 303MF10111

    Registrant's Address : No. 100 Waisha Branch Rd. , Jiaojiang, Taizhou, Zhejiang, China

    Initial Date of Registration : 2021-07-16

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Ace Biopharm Co., Ltd.

    Registration Date : 2019-12-04

    Registration Number : 20191204-211-J-495

    Manufacturer Name : Zhejiang Hisoar Pharmaceutical Co., Ltd

    Manufacturer Address : No. 100 Waisha Branch Road. Jiaojiang, Taizhou, China

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Metoprolol Succinate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    India Med Expo
    Not Confirmed
    arrow

    Metoprolol Succinate

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    India Med Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-09-12

    Pay. Date : 2014-01-17

    DMF Number : 21454

    Submission : 2008-03-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2010-109 - Rev 02

    Issue Date : 2024-09-27

    Type : Chemical

    Substance Number : 1448

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 67321-509

    Start Marketing Date : 2015-02-22

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Quetiapine Hemifumarate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    India Med Expo
    Not Confirmed
    arrow

    Quetiapine Hemifumarate

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    India Med Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2015-218 - Rev 00

    Issue Date : 2022-02-15

    Type : Chemical

    Substance Number : 2541

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 229MF10146

    Registrant's Address : No. 23,5th Donghai Avenue Zhejiang Chemical materials base Linhai zone, Linhai City, Zhejiang Province, China.

    Initial Date of Registration : 2017-07-31

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Repaglinide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    India Med Expo
    Not Confirmed
    arrow

    Repaglinide

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    India Med Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2008-201 - Rev 06

    Issue Date : 2024-04-29

    Type : Chemical

    Substance Number : 2135

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 306MF10117

    Registrant's Address : No. 23,5th Donghai Avenue Zhejiang Chemical materials base Linhai zone, Linhai City, Zhejiang Province, China.

    Initial Date of Registration : 2024-08-28

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Clindamycin Palmitate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    India Med Expo
    Not Confirmed
    arrow

    Clindamycin Palmitate

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    India Med Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-06-17

    Pay. Date : 2013-09-16

    DMF Number : 27276

    Submission : 2013-09-22

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 67321-304

    Start Marketing Date : 2020-11-20

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Clindamycin Phosphate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    India Med Expo
    Not Confirmed
    arrow

    Clindamycin Phosphate

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    India Med Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 226MF10130

    Registrant's Address : No. 23,5th Donghai Avenue Zhejiang Chemical materials base Linhai zone, Linhai City, Zhejiang Province, China.

    Initial Date of Registration : 2014-06-26

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Flunixin Meglumine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    India Med Expo
    Not Confirmed
    arrow

    Flunixin Meglumine

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    India Med Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2016-133 - Rev 00

    Issue Date : 2022-04-14

    Type : Chemical

    Substance Number : 1696

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 67321-001

    Start Marketing Date : 2017-10-19

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF arrow-down
    ✖

    VMF Number : 6162

    Submission : 2016-08-26

    Status : Active

    Type : II

     Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Meropenem

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    India Med Expo
    Not Confirmed
    arrow

    Meropenem

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    India Med Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 228MF10190

    Registrant's Address : No. 23, 5th Donghai Avenue Zhejiang Chemical materials base Linhai zone, Linhai City, Zhejiang Province, China.

    Initial Date of Registration : 2016-10-05

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd. and get a quotation

    Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd. is a supplier offers 32 products (APIs, Excipients or Intermediates).

    Find a price of Clindamycin Hydrochloride bulk with DMF, CEP, JDMF offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Clindamycin Phosphate bulk with DMF, CEP, JDMF offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Amorolfine Hydrochloride bulk with CEP, JDMF offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Metoprolol Succinate bulk with DMF, CEP offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Quetiapine Hemifumarate bulk with CEP, JDMF offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Repaglinide bulk with CEP, JDMF offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Clindamycin Palmitate bulk with DMF offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Clindamycin Phosphate bulk with JDMF offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Flunixin Meglumine bulk with CEP offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Meropenem bulk with JDMF offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Voglibose bulk with JDMF offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Atorvastatin bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Biapenem bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Bifendate bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Caspofungin bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Clindamycin Palmitate bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Crisaborole bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Diquafosol Sodium bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Ertapenem Sodium bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Faropenem bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Florfenicol bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Gamithromycin bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Lifitegrast bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Moxidectin bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Phenylephrine Hydrochloride bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Rivaroxaban bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Rosuvastatin Calcium bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Sacubitril-Valsartan bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Sofalcone bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Tacrolimus bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Thiamphenicol bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Find a price of Vortioxetine Hydrobromide bulk offered by Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search